BRAINSTORM CELL THERAPEUTICS INC. (Nasdaq:BCLI)
Brainstorm Cell Therapeutics, Inc. is a biotechnology company, which develops and commercializes autologous cellular therapies for the treatment of neurodegenerative diseases, including Amyotrophic Lateral Sclerosis, Progressive Multiple Sclerosis, Alzheimer's disease, and other neurodegenerative diseases. Its pipeline, NurOwn proprietary cell therapy platform, leverages cell culture methods to induce autologous bone marrow-derived mesenchymal stem cells to secrete high levels of neurotrophic factors, modulate neuroinflammatory and neurodegenerative disease processes, promote neuronal survival, and improve neurological function. The company was founded by Irit Arbel on September 22, 2000 and is headquartered in New York, NY.
1325 Avenue of Americas
28th floor
New York, New York 10019
29
$1.5800
1.5500 - 1.6999
1.0500 - 11.8905
73.48K
110.85K (02/14/25)
2.50%
$9.01M
N/A
-$17.19M
N/A
|
Secretary, Director, Chief Business Officer & EVP Uri Yablonka |
|
Chairman Jacob Aharon Frenkel |
|
Independent Director Nir Naor |
|
Vice Chairman Irit Arbel |
|
Independent Director Anthony J. Polverino |
|
Independent Director Menghisteab Bairu |
| Date | Form | Event |
|---|---|---|
| 14 Nov, 2024 | 8-K | |
| 14 Nov, 2024 | SC 13G | |
| 14 Nov, 2024 | 10-Q | |
| 13 Nov, 2024 | SC 13G | |
| 30 Oct, 2024 | 8-K | |
| 2 Oct, 2024 | 4 | |
| 1 Oct, 2024 | 8-K | |
| 1 Oct, 2024 | 8-K | |
| 27 Sep, 2024 | EFFECT | |
| 26 Sep, 2024 | 8-K | |
| 26 Sep, 2024 | CORRESP | |
| 24 Sep, 2024 | S-3/A | |
| 24 Sep, 2024 | CORRESP | |
| 20 Sep, 2024 | UPLOAD | |
| 17 Sep, 2024 | S-3 | |
| 16 Sep, 2024 | 8-K | |
| 6 Sep, 2024 | EFFECT | |
| 4 Sep, 2024 | CORRESP | |
| 3 Sep, 2024 | UPLOAD | |
| 28 Aug, 2024 | S-3 | |
| 16 Aug, 2024 | DEF 14A | |
| 16 Aug, 2024 | ARS | |
| 14 Aug, 2024 | 8-K | |
| 14 Aug, 2024 | 10-Q | |
| 6 Aug, 2024 | PRER14A | |
| 5 Aug, 2024 | PRE 14A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 31 Jul, 2024 | 4/A | |
| 30 Jul, 2024 | 8-K | |
| 24 Jul, 2024 | 4 | |
| 19 Jul, 2024 | 8-K | |
| 28 Jun, 2024 | 8-K | |
| 28 Jun, 2024 | 424B5 | |
| 27 Jun, 2024 | 424B5 | |
| 26 Jun, 2024 | 8-K | |
| 25 Jun, 2024 | 4 | |
| 25 Jun, 2024 | 3 | |
| 20 Jun, 2024 | 8-K | |
| 4 Jun, 2024 | 8-K | |
| 3 Jun, 2024 | 4 | |
| 23 May, 2024 | 4 | |
| 14 May, 2024 | 10-Q | |
| 14 May, 2024 | 4 | |
| 7 May, 2024 | 4 | |
| 7 May, 2024 | 4 | |
| 3 May, 2024 | 8-K | |
| 25 Apr, 2024 | 4 | |
| 22 Apr, 2024 | 3 | |
| 19 Apr, 2024 | 4 | |
| 17 Apr, 2024 | 8-K | CEO Change |
| 11 Apr, 2024 | 8-K | |
| 9 Apr, 2024 | 8-K | |
| 2 Apr, 2024 | 8-K | |
| 2 Apr, 2024 | 424B5 | |
| 1 Apr, 2024 | 8-K | |
| 1 Apr, 2024 | 10-K | |
| 13 Mar, 2024 | 4 | |
| 13 Mar, 2024 | 4 | |
| 13 Mar, 2024 | 4 | |
| 13 Mar, 2024 | 4 | |
| 12 Feb, 2024 | SC 13G/A | |
| 20 Dec, 2023 | 8-K | |
| 22 Nov, 2023 | DEFA14A | |
| 22 Nov, 2023 | 8-K | |
| 14 Nov, 2023 | 8-K | |
| 14 Nov, 2023 | 10-Q | |
| 9 Nov, 2023 | 8-K | |
| 8 Nov, 2023 | DEF 14A | |
| 3 Nov, 2023 | 8-K | |
| 24 Oct, 2023 | 8-K | |
| 5 Sep, 2023 | 4 | |
| 14 Aug, 2023 | 8-K | |
| 14 Aug, 2023 | 10-Q | |
| 7 Aug, 2023 | 4 | |
| 4 Aug, 2023 | 4 | |
| 19 Jul, 2023 | 8-K | |
| 19 Jul, 2023 | 424B5 | |
| 21 Jun, 2023 | 4 | |
| 21 Jun, 2023 | 3 | |
| 6 Jun, 2023 | 8-K | |
| 24 May, 2023 | 8-K | |
| 15 May, 2023 | 8-K | |
| 15 May, 2023 | 10-Q | |
| 1 May, 2023 | 3 | |
| 1 May, 2023 | 4 | |
| 24 Apr, 2023 | 4 | |
| 24 Apr, 2023 | 4 | |
| 5 Apr, 2023 | SC 13G/A | |
| 30 Mar, 2023 | 10-K | |
| 30 Mar, 2023 | 8-K | |
| 27 Mar, 2023 | 8-K | |
| 11 Jan, 2023 | 8-K | |
| 4 Jan, 2023 | 8-K | |
| 4 Jan, 2023 | 4 | |
| 4 Jan, 2023 | 4 | |
| 13 Dec, 2022 | DEF 14A | |
| 14 Nov, 2022 | 8-K | |
| 14 Nov, 2022 | 10-Q | |
| 12 Oct, 2022 | 8-K | |
| 22 Sep, 2022 | 8-K | |
| 15 Aug, 2022 | 10-Q | |
| 15 Aug, 2022 | 8-K | |
| 16 May, 2022 | 10-Q | |
| 16 May, 2022 | 8-K | |
| 8 Apr, 2022 | 4 | |
| 28 Mar, 2022 | 8-K | |
| 28 Mar, 2022 | 10-K | |
| 14 Mar, 2022 | 4 | |
| 14 Feb, 2022 | SC 13G | |
| 4 Feb, 2022 | SC 13G | |
| 3 Feb, 2022 | 4 | |
| 28 Jan, 2022 | 8-K | |
| 17 Dec, 2021 | 4 | |
| 17 Dec, 2021 | 4 | |
| 17 Dec, 2021 | 4 | |
| 17 Dec, 2021 | 4 | |
| 17 Dec, 2021 | 4 | |
| 17 Dec, 2021 | 8-K | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | S-8 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 10 Dec, 2021 | 4 | |
| 15 Nov, 2021 | 10-Q | |
| 4 Nov, 2021 | 3 | |
| 4 Nov, 2021 | DEF 14A | |
| 29 Oct, 2021 | 8-K | |
| 2 Sep, 2021 | 3 | |
| 25 Aug, 2021 | 8-K | |
| 19 Aug, 2021 | EFFECT | |
| 17 Aug, 2021 | CORRESP | |
| 16 Aug, 2021 | UPLOAD | |
| 13 Aug, 2021 | 8-K | |
| 9 Aug, 2021 | S-3 | |
| 5 Aug, 2021 | 8-K | |
| 5 Aug, 2021 | 10-Q | |
| 12 Jul, 2021 | SC 13G/A | |
| 28 May, 2021 | 8-K | |
| 26 Apr, 2021 | 8-K | |
| 26 Apr, 2021 | 10-Q | |
| 4 Feb, 2021 | 8-K | |
| 4 Feb, 2021 | 10-K | |
| 2 Feb, 2021 | SC 13G |
Sign Up to Subscribe
Interested in special situations?
Join Tickerverse
- customize event filters
- create watchlists, bookmarks
- get email notifications for the latest special situations
- browse and analyze public companies, executives and SEC filings
Tickerverse is a great way to find investment opportunities in corporate actions.
By signing up you agree to our Terms of Service and Privacy Policy.